Background. Cardiovascular diseases (CVD) constitute major cause of death in patients with chronic kidney disease (CKD). It is well established that in decreased renal function is associated with an increased risk of arterial stiffness, so patients with end stage renal disease have a very high risk for cardiovascular events. There have been no reports of the assessment of arterial stiffness in patients at different stages of non diabetic CKD in Mongolia.Aim. The purpose of this study was to determine the correlation between an estimated glomerular filtration rate (eGFR) and cardio-ankle vascular index (CAVI) in the CKD patients. Material and Methods. From a hospital-based population, 125 patients with CKD (mean age 40.30±10.82) were recruited. CKD was evaluated by the eGFR using the Cockcroft-Gault formula. CAVI was determined as an index of arterial stiffness.Results. The mean CAVI was in CKD level l ( 6.00±0.81, p 0.0001), ll (6.90±0.77, p 0.0001), lll (7.42±0.65, p 0.0001), lV (7.63±1.22, p 0.0001) and V (8.02±1.27, p 0.0001). CAVI was negatively correlated significantly with eGFR (r=-0.596, p 0.0001) and age (r=0.543, p 0.0001). Linear regression analysis indicated that CAVI was correlated significantly with eGFR (β=-0.466, p 0.0001) and age (β=0.373, p 0.0001).Conclusion. Decreased eGFR is associated with an increased risk of arterial stiffness, and it could be a strong predictor of risk factor for CVD in CKD patients.

Background: The World Health Organization calls hypertension the number one risk factor for death in the world and it’s considered a significant risk for stroke, heart failure, and kidney failure. Hypertension is common in patients with chronic kidney disease (CKD), and high blood pressure (BP) has been associated with a decrease in kidney function. The purpose of this study was to determine the correlation between an estimated glomerular filtration rate (eGFR) and BP in the CKD patients. Methods: From a hospital-based population, 125 patients with CKD (mean age 40.30±10.82) were recruited. CKD was evaluated by the eGFR using the Cockcroft-Gault formula. Cardio-Ankle vascular index (CAVI) was determined as an index of arterial stiffness. BP was measured using a mercury sphygmomanometer after subjects had sat and rested for at least 15 minutes. Pulse pressure was calculated as the difference between systolic BP (SBP) and diastolic BP (DBP). Mean arterial pressure was calculated as DBP plus one-third (SBP-DBP).Results: When BP grows up, renal function (eGFR 113.72±57.85, 78.39±60.96, 60.56±55.71, 28.38±19.96) and arterial stiffness (CAVI 6.51±0.99, 6.90±1.05, 7.22±1.17, and 7.79±1.16) are decreased. Linear regression analysis indicated that eGFR was correlated significantly with SBP (β=-0.480, p< 0.0001) and hypertension time (β=-0.332), p<0.0001). SBP was the strongest risk factors for CKD with each SD increase in systolic blood pressure (1mmHg) associated with > 4% higher risk ( hazard ratio: 1.04; 95% Cl: 1.02-1.07).Conclusion: Increases SBP were significantly associated with CKD.

Abstract: Diabetes is describe as a disease of the thirst (undaasah) in the four foundations of traditional drug (Kh. Tumbaa, 1991).
There are drugs such as Jur Ur-4, Sopagi-14, Yunva-4 and Usu-3 used for thirst disease. One of the main medicines used in Mongolian traditional drug is “Usu-3”. This is drug with 3 ingredients (Coriandrum sativum L.), (Inula helenium L.), (Hippophae rhamnoides L.). Each of these ingredients were studied indivudually, but not studied in combination. Purpose: To study liver protection effects and toxicity of the “Usu-3” traditional drug in the pathological diabetic model. Methods: The experiment were performed using acute and chronic toxicity study by Organization economic cooperation development (OECD 423), effect of antihyperglycemic and antihyperlipidemic on the alloxan induced diabetic milletus. (Sheriff Modu*, A. Laila et al, 2011) and (Ju JB, Kim JS et al, 2008) method. Results:
1. The “Usu-3” traditional drug was tested in animals at a dose of 5 to 5000 mg/kg in accordance with OECD guideline 423 for acute toxicity study and was found to be harmless in the GHS category. Therefore showed no signs of chronic poisoning with the maximum dose determined for chronic toxicity studies oral administration by 5000mg/kg for 2 months.
2. The “Usu-3” traditional drug’s group has been shown to reducing the levels of Aspartate Aminotransferase and Alanine Aminotransferease comparison with other groups. Conclusion “Usu-3” traditional drug was found to be harmless in the GHS category, showed no signs of acute and chronic toxicity.
“Usu-3” traditional drug have a protection effect for liver at short and medium time in alloxan induced diabetic rats model.

Abstract: Noncommunicable diseases (NCDs) kill 41 million people each year, equivalent to 71% of all deaths globally and diabetes is one of the top 5 causes of these diseases.According to Mongolia's health statistics, diabetes accounted for 41.5% of all diseases of endocrine, nutritional and metabolic disorders and the morbidity rate was 82.9 per 10 000 population in 2018.
We chose to study the Usu-3 traditional medicine, which has been used in medicine for diabetes. Purpose: The study of effects for "Usu-3" traditional medicine in alloxan-induced diabetic model Methods: The experiment were performed using (Sheriff Modu*, A. Laila et al, 2011) and (Ju JB, Kim JSet al, 2008) method. Results: The "Usu-3" traditional drug has been shown to have a gradual effect on lowering serum glucose in short time and normal level in medium time. Therefore as well as normal levels of lipids in all groups. Conclusion "Usu-3" traditional drug has been shown to gradually lower blood serum glucose and when to study the antihyperglycaemic and antihyperlipidaemic effects of "Usu-3" traditional drug at in alloxan induced diabetic rats.

Background. Demographic transition is indication of population growth rates which impacted by global environmental changes and development of modern science. Last years, number of elderly people dramatically increasing in the world and this increases also showed up in Mongolia. Therefore, investigating the ageing process, risk factors for ageing and age related changes of the human body is important for diagnosing and decreasing age-related disease, improving the quality of life in elderly and healthy ageing. We aimed to investigate age related changes of antioxidant and prooxidant status among healthy Mongolian adults.Materials and Methods. 384 healthy subjects participated in this research. We measured serum level of antioxidant and prooxidant parameters in all subjects at the Functional diagnostic laboratory and Immunology laboratory of the Health Sciences University of Mongolia.Results. Serum level of malondialdehyde (MDA) that is parameter of prooxidant activity was lower in the 21-30 age groups and highest in upper 70 age groups. There was a significantly positive correlation between age and serum MDA level (r=0.665, p 0.01). Serum antioxidant parameters such as superoxide dismutase (SOD, r=-0.357, p 0.01), glutathione (GSH, r=-0.201, p 0.01) and total antioxidant activity (TAC, r=-0.256, p 0.01) has a negative correlation with age. But glutathione peroxidase (GPx, r=0.635, p 0.01) was significantly increased with age. That means the antioxidant activity is decreasing with the ageing process. Regression analyses showed that MDA, GPx, SOD, GSH, and TAC were significantly related with the ageing process.Conclusion. We concluded that the antioxidant activity is decreasing and oxidation process is increasing with age and oxidative stress is higher in healthy Mongolian adults. Furthermore, the serum lipid level is increasing from age 40and it can be the reason for arterial wall thickness.

Background: High blood pressure is both a cause and a complication of chronic kidney disease. As complication, high blood pressure may develop early during course of chronic kidney disease and is associated with adverse outcomes, in particular faster loss of kidney function and development of cardiovascular disease. The purpose of this study is early detection of chronic kidney disease in patients with hypertension by defining the prevalence of microalbuminuria.Methods: The study population consisted of 169 subjects with a hypertension. Individuals were considered to have hypertension if the blood pressure measured greater than 140/90 mmHg or if they were taking blood pressure lowering medications. Microalbuminuria was defined as 20 mg/l or greater. Results: We are presenting data on 169 subjects :male 38 (22.5%) female 131 (77.5%), average age 51.6±0.89 At screening, 14.8% of all participants were smokers, 62.1 % engaged in low levels of physical activity, 72.8% - were having tea with salt (table1). Microalbuminuria and renal failure, as GFR<60 ml/ min/1.73 m2, were documented in 34.3% and 16.6% of subjects, respectively. There is positive correlation between MAU and increasing-range of blood pressure (table2). Correlation was found between albuminuria and GFR(r= -0.2 p<0.01) and serum creatinine(r=0.31 p<0.01) the regression result has shown that GFR is associated with MAU and serum creatinine (table 3).Conclusions:1. In 34.3% of patient with hypertension was found nephropathies with MAU2. Microalbuminuria is increased with decline of GFR and raise of systolic blood pressure. GFR decline is with the raise of age and serum. It is important to implement in clinical practice screening of MAU hypertensive patients.3. In 2/3 of all screened subjects was found 1 and more risk factors for CVD.

IntroductionNowadays the risk factors for thrombosis include blood stasis, vessel wall injury, and hypercoagulability, as proposed by Virchow over 150 years ago. We chose to study affect of Zomoshin 6 tan to the model of thrombosis formed in experimental animal. It was written in books and sudar that it has action of treating some type’s disease such as blood diluting, meeting frozen blood and treating some gynecological disease.PurposeTo study affect of Zomoshin-6 tan deep vein thrombosis model formed in experimental animal.Material and Methods30 male rats of wistar bread with 180-220 gram of weight for control group, experimental group or Zomoshin-6 tan and comparative group Warfarin. Thirty rats were equally divided into 3 groups: Group 1 received saline alone, Group 2 received Zomoshin-6 (200 mg/kg), and Group 3 received Warfarin as a positive control (0.25 mg/kg), seven days prior to the assessment of thrombus formation. Thrombus formation was also assessed histopathologically. Thrombi were detected in all rats after experimentallyinduced thrombosis.ResultsHistological analysis demonstrated the presence of thrombosis in the interior vena cava (IVC) of the control group, which contained fibrin, erythrocytes, and leucocytes and obstructed the lumen. Only a small amount of fibrin clot, containing a few leucocytes and large numbers of erythrocytes, were observed in the Zomoshin-6-treated group. The thrombus formed in the IVC of Warfarin-treated animals consisted of fibrin clot, which was mostly attached to the wall, with few leucocytes but abundant erythrocytes. These findings suggest that Zomoshin-6 is an effective antithrombotic agent.Conclusion:Zomoshin-6 tan has an action of inhibing thrombosis forming of vein in experimental animal.

Introduction. Garidi-5, a traditional medicine composed of 5 herbs including Terminalia chebula Retz., Aconitum Kusnezoffii Reichb., Acorus calamus L., Saussurea lappa L., and musk of Moschus moschiferus, has been used in traditional Mongolian medicine as an analgesic and antibacterial medicine. The present work was undertaken to evaluate the traditional drug Garidi-5 for its analgesic and anti-inflammatory activity.Materials and Methods. The method of Winter et al. was used to study acute inflammation. Rats in groups of five each were treated with vehicle, Garidi-5 (20, 80 and 200 mg/kg, p.o.) and Indometacin (10 mg/kg) one hour prior to Carrageenan injection. 0.1 ml of 1% Carrageenan was injected into the subplantar tissue of left hind paw of each rat. Swelling of carrageenan injected foot was measured at 0, 0.5, 2, 4 h using Plethysmometer (UGO Basile, Italy)). The right hind paw was injected with 0.1 ml of vehicle.Results. The Garidi-5 (20, 80 and 200 mg/kg) significantly (P<0.01) inhibited carrageenan induced rat paw edema as compared to control group. Maximum inhibition of paw edema was observed with Garidi- 5 (80 and 200 mg/kg) at 4 h when compared to the control group (Tab.1). In assay data, the TNF-α, IL-1β and IL-6 secretion in serum were highly elevated by carrageenan induction but administration of Garidi-5 signifi cantly reduced serum secretion of inflammatory mediatorsas compared to vehicle group (Tab. 2).Conclusion. In conclusion, Traditional drug Garidi-5 have anti-in flammatory properties. The potential efficacy of Garidi-5 to treat inflammation is based in a part on the hy pothesis that it will suppress the proinflammatory cytok ines resulting in less oedema.

Introduction. Garidi-5, a traditional medicine composed of 5 herbs including Terminalia chebula Retz. Aconitum Kusnezoffii Reichb., Acorus calamus L., Saussurea lappa L., and musk of Moschus moschiferus, has been used in traditional Mongolian medicine as an analgesic and antibacterial medicine. The present work was undertaken to evaluate the traditional drug Garidi-5 for its analgesic and anti-inflammatory activity.Materials and Methods. The method of Winter et al. was used to study acute inflammation. Rats in groups of five each were treated with vehicle, Garidi-5 (20, 80 and 200 mg/kg, p.o.) and Indometacin (10 mg/kg) one hour prior to Carrageenan injection. 0.1 ml of 1% Carrageenan was injected into the subplantar tissue of left hind paw of each rat. Swelling of carrageenan injected foot was measured at 0, 0.5, 2, 4 h using Plethysmometer (UGO Basile, Italy)). The right hind pawwas injected with 0.1 ml of vehicle.ResultsThe Garidi-5 (20, 80 and 200 mg/kg) significantly (P<0.01) inhibited carrageenan induced rat paw edema as compared to control group. Maximum inhibition of paw edema was observed with Garidi-5 (80 and 200 mg/kg) at 4 h when compared to the control group (Tab.1). In assay data, the TNF-α, IL-1β and IL-6 secretion in serum were highly elevated by carrageenan induction but administration of Garidi-5 signifi cantly reduced serum secretion of inflammatory mediators as compared to vehicle group (Tab. 2). ConclusionIn conclusion, Traditional drug Garidi-5 have anti-in flammatory properties. The potential efficacy of Garidi-5 to treat inflammation is based in a part on the hy pothesis that it will suppress the proinflammatory cytok ines resulting in less oedema.

BACKGROUND. According to the World Health Organization (WHO), 10-15% of couples of reproductive age have infertility. According to researcher D. Sukhe (1999), hormonal infertility in the reproductive age of women was 33.6%, which was a large part of the cause of infertility. In recent years, the number of cases of endocrine disorders, including malignancy and sexually transmitted infections, have been increasing year by year. According to WHO reports, thyroid disorders have a prevalence of 49.3% among active reproductive age (30-50) group. According to the report of the Health Development Center in 2016, since the thyroid disorders are the second most common disease in endocrine gland disease, our study has found that the infertility in reproductive age of women can be substantial due to the loss of thyroid gland. OBJECTIVE. To study the relationship between the thyroid gland antibodies and female infertility. MATERIAL AND METHODS. The study was carried out in 20-45 year old couples and was modeled as an analytical study model. The questionnaire was used for the couple’s interviews, antroplogical measurements, and serum was analysed. On the serum, anti-TPO and аnti-TG carbohydrates were identified by the Cobas e-411 analyzer under the manufacturer’s accompanying protocol. RESULTS. Prevalence of TAI, in 6.7% positive anti-Tg were found, and 14.3% had positive TPO. In 3.7% of cases, both types of autoantibodies were present. We analysed binary logistic regression for anti-TPO and anti-TG autoantibody in the positive and negative group in relation to the past obstetrics history. A=Accoding to the analysis, evidence of positive anti-TPO and anti-Tg increased the risk of miscarriage by 2.2 times (OR = 2.2, p <0.01). CONCLUSION: Women with infertility in our study have high percentage of subclinical hypothyroidism and have higher rate of thyroid autobodies in serum which could be a problem for women with infertility and pregnancy complications due to the loss of thyroid gland. Thus, there is a need to develop intervention guidelines for recovery and treatment of these types of infertility.